Structure-Activity Relationships in Purine-Based Inhibitor Binding to Hsp90 Isoforms
Wright, L., Barril, X., Dymock, B., Sheridan, L., Surgenor, A., Beswick, M., Drysdale, M., Collier, A., Massey, A., Davies, N., Fink, A., Fromont, C., Aherne, W., Boxall, K., Sharp, S., Workman, P., Hubbard, R.E.(2004) Chem Biol 11: 775
- PubMed: 15217611 
- DOI: 10.1016/j.chembiol.2004.03.033
- Primary Citation of Related Structures:  
1UYL, 1UYK, 1UYI, 1UYH, 1UYG, 1UYF, 1UYE, 1UYM, 1UY9, 1UY8 - PubMed Abstract: 
Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers. We have determined structures of the HSP90alpha N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enha ...